Credit Suisse’s Akili Inc AKLI Stock Holding History

Credit Suisse’s Portfolio AKLI Stock Details AKLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300,000	Closed	-$2.98M	–	4703
2021 Q3	$2.98M	Buy	+300,000	New	+$2.96M	﹤0.01%	2500

Other funds holding AKLI

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse's AKLI Position: Q4 2021 in Review

Credit Suisse sold out of Akili Inc (AKLI) in Q4 2021, closing a stake of 300,000 shares — an estimated $2.98M sold.

Credit Suisse first reported a position in AKLI in Q3 2021 and held it in 1 quarter. The position peaked at $2.98M in Q3 2021. 89 funds tracked by Wall St. Rank hold AKLI as of Q4 2021.

Credit Suisse reported no remaining Akili Inc position as of Q4 2021 after selling out during the quarter.
Credit Suisse sold 300,000 Akili Inc shares in Q4 2021, an estimated $2.98M.
Credit Suisse first reported a position in Akili Inc in Q3 2021 and held it in 1 quarter.
Credit Suisse's Akili Inc position peaked at $2.98M in Q3 2021.
89 funds tracked by Wall St. Rank held Akili Inc as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.